Definium Therapeutics develops psychedelic-based therapeutics for psychiatric and neurological disorders. Backed by North Carolina Biotechnology Center.
About the role
Together we are moving psychiatry forward—beyond better, into a boundless future. Join us! This role requires both strategic leadership and hands‑on execution , with the ability to operate effectively in a lean, fast‑moving organization.
What they're looking for
- Doctoral degree preferred (MD, PhD, PharmD, PsyD)
- 6-8+ years of clinical development experience in the pharmaceutical or biotechnology industry
- Demonstrated experience leading Expanded Access programs and late‑stage, post‑approval programs
- Experience selecting and managing third-party vendors to support operational functions of Expanded Access and late-stage evidence programs
- CNS clinical development experience in psychiatry strongly preferred
- Experience with budget ownership to include forecasting tracking, and managing across multiple programs
More about this role
Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.
Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.
Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq...
Browse similar: Startup jobs · Remote jobs